Effective Management of Psoriatic Arthritis: Tailoring Treatments
Psoriatic Arthritis Clinical Manifestations
Psoriatic Arthritis Clinical Manifestations (cont)
Psoriatic Arthritis Clinical Manifestations (cont)
Psoriatic Arthritis Comorbidities
Psoriatic Arthritis Contributing Factors to Psoriasis
Key Cells and Mediators: Transition From Innate to Adaptive Immunity
Pathogenesis of Psoriatic Arthritis
Treatment of Psoriatic Arthritis
Newer Treatment Options
Emerging Treatments for Psoriatic Arthritis
Treatment of Psoriatic Arthritis The Pathophysiologic Cascade
Cytokine Signaling Pathways cAMP/PKA
Ustekinumab Inhibits p40 Moiety
IL-17 Inhibitors
Cytokine Signaling Pathways JAK
Mechanism of Action of Abatacept
Guselkumab: IL-23, p19
New Domain Core Set for Psoriatic Arthritis
Core Domains to Evaluate in Clinical Trials
GRAPPA 2015 Treatment Recommendations
GRAPPA 2015 Treatment Recommendations: Peripheral Arthritis
GRAPPA 2015 Treatment Recommendations: Axial Disease
GRAPPA 2015 Treatment Recommendations: Enthesitis and Dactylitis
GRAPPA 2015 Treatment Recommendations: Skin and Nails
Case: Aggressive Disease 55-Year-Old Man
Joint Examination
Choosing a Therapy
GRAPPA Minimal Disease Activity Criteria
Case: Disease Progression 40-Year-Old Woman
Evaluation for Inflammatory Back Pain
Treatment and Management
Concluding Remarks
Abbreviations
Abbreviations (cont)
Abbreviations (cont)
Abbreviations (cont)